A team of healthcare professionals from the Cleveland Clinic detailed in JACC: Cardiovascular Interventions how they improved efficiency in their cardiac catheterization lab, providing a potential blueprint for other practices.

DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women's Initiative focused on heart recovery education and awareness.

The FDA has expanded its premarket approval for Impella heart pumps to include treatment for heart failure associated with cardiomyopathy leading to cardiogenic shock, device manufacturer Abiomed announced Feb. 13.

Amy Sherald was 30 years old, finishing graduate school and training for a triathlon in 2004 when she decided to see a doctor. She had a recurring dream since childhood in which she ran a marathon and died, according to a 2016 Baltimore Magazine story, so she just wanted to ease her mind.

A team of researchers has developed a risk score containing five readily available factors that predict the odds of stroke for heart attack patients with reduced ejection fraction but without atrial fibrillation (AFib).

Survivors of childhood heart defects are more likely than the general population to develop dementia, including at earlier ages, researchers reported Feb. 12 in Circulation.

Women diagnosed with gestational diabetes mellitus (GDM) are at a very high risk of developing Type 2 diabetes and have a significantly increased incidence of hypertension and ischemic heart disease (IHD), according to recently published research in PLoS Medicine.

Direct oral anticoagulants (DOACs) provide additional benefit to antiplatelet therapy following acute coronary syndrome (ACS)—but only for ST-segment elevation myocardial infarction (STEMI)—according to a meta-analysis in JAMA Cardiology.